Biomimetic polymers in pharmaceutical and biomedical sciences

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 58, Issue 2, 2004, Pages 385-407

  Drotleff, S ^a   Lungwitz, U ^a   Breunig, M ^a   Dennis, A ^a,b   Blunk, T ^a   Tessmar, J ^c   Gopferich A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c Rice University   (United States)

Author keywords

Biomaterial; Biomimetic; Cell signaling; Drug targeting; Gene therapy; Surface attachment; Tissue engineering

Indexed keywords

ALGINIC ACID; BIOMIMETIC MATERIAL; CHITOSAN; CYANAMIDE; FIBRIN; FUMARIC ACID DERIVATIVE; HEPARIN BINDING PROTEIN; LECTIN; MACROGOL; NANOPARTICLE; POLY(ETHYLENE GLYCOL) CO POLY(CAPROLACTONE); POLY(ETHYLENE GLYCOL) CO POLY(ETHYLENEIMINE); POLY(ETHYLENE GLYCOL) CO POLY(LEVO LACTIC ACID); POLY(METHYL METHACRYLATE); POLYACRYLIC ACID; POLYETHYLENEIMINE; POLYETHYLENEIMINE DERIVATIVE; POLYGLACTIN; POLYLACTIC ACID; POLYLYSINE; POLYMER; POLYPROPYLENE; POLYSTYRENE; UNCLASSIFIED DRUG;

AMINATION; BIOMEDICAL ENGINEERING; BIOMIMETICS; CELL ADHESION; CELL INTERACTION; CHEMICAL REACTION KINETICS; CROSS LINKING; DRUG ACTIVITY; ENDOCYTOSIS; EXPRESSION VECTOR; GENE DELIVERY SYSTEM; GENE TARGETING; GENE THERAPY; HYDROGEL; HYDROPHILICITY; LIPOPHILICITY; MOLECULAR MECHANICS; NANOTECHNOLOGY; NONHUMAN; PHARMACEUTICAL ENGINEERING; POLYMERIZATION; PROCESS DESIGN; PROCESS DEVELOPMENT; PROTEIN BINDING; REDUCTION; REVIEW; SIGNAL TRANSDUCTION; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; BIOMIMETIC MATERIALS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; LIGANDS; NANOSTRUCTURES; POLYMERS; RECEPTORS, CELL SURFACE; SURFACE PROPERTIES; TISSUE ENGINEERING;

EID: 3843124278     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2004.03.018     Document Type: Review

References (176)

1. Hoecker H. Polymeric materials as biomaterials under particular consideration of biodegradable polymers. Macromol. Symp. 130:1998;161-168
2. Langer R., Cima L.G., Tamada J.A., Wintermantel E. Future directions in biomaterials. Biomaterials. 11:1990;738-745
3. Zhou S., Liao X., Li X., Deng X., Li H. Poly-D,L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems. J. Controlled Release. 86:2003;195-205
4. Bonassar L.J., Vacanti C.A. Tissue engineering: the first decade and beyond. J. Cell Biochem. 30/31:1998;297-303
5. Hubbell J.A. Biomaterials in tissue engineering. Bio/Technology. 13:1995;565-576
6. James K., Kohn J. New biomaterials for tissue engineering. MRS Bull. 1996;22-26
7. Hutmacher D.W., Goh J.C., Teoh S.H. An introduction to biodegradable materials for tissue engineering applications. Ann. Acad. Med. Singapore. 30:2001;183-191
8. Langer R. Biomaterials and biomedical engineering. Chem. Eng. Sci. 50:1995;4109-4121
9. Klee D., Hoecker H. Polymers for biomedical applications: improvement of the interface compatibility. Adv. Polym. Sci. 149:1999;1-57
10. Lucke A., Tessmar J., Schnell E., Schmeer G., Gopferich A. Biodegradable poly(D,L-lactic acid)-poly(ethylene glycol)-monomethyl ether diblock copolymers: structures and surface properties relevant to their use as biomaterials. Biomaterials. 21:2000;2361-2370
11. Ratner B.D. The engineering of biomaterials exhibiting recognition and specificity. J. Mol. Recogn. 9:2002;617-625
12. Ratner B.D. Molecular design strategies for biomaterials that heal. Macromol. Symp. 130:1998;327-335
13. Mann B.K., Schmedlen R.H., West J.L. Tethered-TGF-[beta] increases extracellular matrix production of vascular smooth muscle cells. Biomaterials. 22:2001;439-444
14. Kuhl P.R., Griffith-Cima L.G. Tethered epidermal growth factor as a paradigm for growth factor-induced stimulation from the solid phase. Nature Med. 2:1996;1022-1027
15. Kantlehner M., Schaffner P., Finsinger D., Meyer J., Jonczyk A., Diefenbach B., Nies B., Holzemann G., Goodman S.L., Kessler H. Surface coating with cyclic RGD peptides stimulates osteoblast adhesion and proliferation as well as bone formation. Chembiochem. 1:2000;107-114
16. Shin H., Zygourakis K., Farach-Carson M.C., Yaszemski M.J., Mikos A.G. Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials. 25:2004;895-906
17. Bhadriraju K., Hansen L.K. Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins. Biomaterials. 21:2000;267-272
18. Mann B.K., Tsai A.T., Scott B.T., West J.L. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials. 20:1999;2281-2286
19. Cho C.W., Cho Y.S., Lee H.K., Yeom Y., Park I.S.N., Yoon D.Y. Improvement of receptor-mediated gene delivery to HepG2 cells using an amphiphilic gelling agent. Biotechnol. Appl. Biochem. 32:(Pt 1):2000;21-26
20. Stayton P.S., Hoffman A.S., Murthy N., Lackey C., Cheung C., Tan P., Klumb L.A., Chilkoti A., Wilbur F.S., Press O.W. Molecular engineering of proteins and polymers for targeting and intracellular delivery of therapeutics. J. Controlled Release. 65:2000;203-220
21. Cima L.G. Polymer substrates for controlled biological interactions. J. Cell Biochem. 56:1994;155-161
22. Blunk T., Gopferich A., Tessmar J. Special issue biomimetic polymers. Biomaterials. 24:2003;4335-4335
23. Shin H., Jo S., Mikos A.G. Biomimetic materials for tissue engineering. Biomaterials. 24:2003;4353-4364
24. Hacker M., Tessmar J., Neubauer M., Blaimer A., Blunk T., Gopferich A., Schulz M.B. Towards biomimetic scaffolds: anhydrous scaffold fabrication from biodegradable amine-reactive diblock copolymers. Biomaterials. 24:2003;4459-4473
25. Tessmar J., Mikos A., Gopferich A. The use of poly(ethylene glycol)-block-poly(lactic acid) derived copolymers for the rapid creation of biomimetic surfaces. Biomaterials. 24:2003;4475-4486
26. Ruoslahti E., Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science. 238:1987;491-497
27. Hersel U., Dahmen C., Kessler H. RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials. 24:2003;4385-4415
28. LeBaron R.G., Athanasiou K.A. Extracellular matrix cell adhesion peptides: functional applications in orthopedic materials. Tissue Eng. 6:2000;85-103
29. Shakesheff K., Cannizzaro S., Langer R. Creating biomimetic micro-environments with synthetic polymer-peptide hybrid molecules. J. Biomater. Sci., Polym. Ed. 9:1998;507-518
30. Murphy W.L., Mooney D.J. Molecular-scale biomimicry. Nature Biotechnol. 20:2002;30-31
31. Miller C., Shanks H., Witt A., Rutkowski G., Mallapragada S. Oriented Schwann cell growth on micropatterned biodegradable polymer substrates. Biomaterials. 22:2001;1263-1269
32. Ward J.H., Bashir R., Peppas N.A. Micropatterning of biomedical polymer surfaces by novel UV polymerization techniques. J. Biomed. Mater. Res. 56:2001;351-360
33. Hu Y., Winn S.R., Krajbich I., Hollinger J.O. Porous polymer scaffolds surface-modified with arginine-glycine-aspartic acid enhance bone cell attachment and differentiation in vitro. J. Biomed. Mater. Res. 64A:2003;583-590
34. Ferris D.M., Moodie G.D., Dimond P.M., Gioranni C.W., Ehrlich M.G., Valentini R.F. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials. 20:1999;2323-2331
35. van der F.A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Res. 305:2001;285-298
36. Pierschbacher M.D., Ruoslahti E. Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature (London, UK). 309:1984;30-33
37. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25
38. Massia S.P., Hubbell J.A. An RGD spacing of 440 nm is sufficient for integrin alpha V beta 3-mediated fibroblast spreading and 140 nm for focal contact and stress fiber formation. J. Cell Biol. 114:1991;1089-1100
39. Boudreau N.J., Jones P.L. Extracellular matrix and integrin signalling: the shape of things to come. Biochem. J. 339:1999;481-488
40. Woods A., Couchman J.R. Syndecans: synergistic activators of cell adhesion. Trends Cell Biol. 8:1998;189-192
41. Cardin A.D., Weintraub H.J. Molecular modeling of protein- glycosaminoglycan interactions. Arterioscler. Thromb. Vasc. Biol. 9:1989;21-32
42. Hasenbein M.E., Andersen T.T., Bizios R. Micropatterned surfaces modified with select peptides promote exclusive interactions with osteoblasts. Biomaterials. 23:2002;3937-3942
43. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. Molecular Biology of the Cell. 1994;Garland Publishing, New York/London. pp. 502
44. Gref R., Couvreur P., Barratt G., Mysiakine E. Surface-engineered nanoparticles for multiple ligand coupling. Biomaterials. 24:2003;4529-4537
45. Ferrara N., Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25
46. Powers C.J., McLeskey S.W., Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer. 7:2000;165-197
47. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934
48. Trippel S.B. Growth factor actions on articular cartilage. J. Rheumatol., Suppl. 43:1995;129-132
49. Chen P., Gupta K., Wells A. Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis. J. Cell Biol. 124:1994;547-555
50. Schultz G., Rotatori D.S., Clark W. EGF and TGF-alpha in wound healing and repair. J. Cell Biochem. 45:1991;346-352
51. Blunk T., Sieminski A.L., Gooch K.J., Courter D.L., Hollander A.P., Nahir A.M., Langer R., Vunjak-Novakovic G., Freed L.E. Differential effects of growth factors on tissue-engineered cartilage. Tissue Eng. 8:2002;73-84
52. Stuart C.A., Furlanetto R.W., Lebovitz H.E. The insulin receptor of embryonic chicken cartilage. Endocrinology. 105:1979;1293-1302
53. Massague J. TGF-b signal transduction. Annu. Rev. Biochem. 67:1998;753-791
54. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. Molecular Biology of the Cell. 1994;Garland Publishing, New York/London. pp. 769
55. Ignotz R.A., Massague J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1986;4337-4345
56. Robey P.G., Young M.F., Flanders K.C., Roche N.S., Kondaiah P., Reddi A.H., Termine J.D., Sporn M.B., Roberts A.B. Osteoblasts synthesize and respond to transforming growth factor-type beta (TGF-beta) in vitro. J. Cell Biol. 105:1987;457-463
57. Lilli C., Marinucci L., Stabellini G., Belcastro S., Becchetti E., Balducci C., Staffolani N., Locci P. Biomembranes enriched with TGF.beta.1 favor bone matrix protein expression by human osteoblasts in vitro. J. Biomed. Mater. Res. 63:2002;577-582
58. Lecanda F., Avioli L.V., Cheng S.L. Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2. J. Cell Biochem. 67:1997;386-396
59. Rickard D.J., Sullivan T.A., Shenker B.J., Leboy P.S., Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev. Biol. 161:1994;218-228
60. Mellman I. Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12:1996;575-625
61. Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J.D. Molecular Biology of the Cell. 1994;Garland Publishing, New York/London. pp. 618-626
62. Stockert R.J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 75:1995;591-609
63. Qian Z.M., Li H., Sun H., Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 54:2002;561-587
64. Mineo C., Anderson R.G.W. Potocytosis. Histochem. Cell Biol. 116:2002;109-118
65. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 169-180
66. Gilles M.A., Hudson A.Q., Borders C.L. Jr. Stability of water-soluble carbodiimides in aqueous solution. Anal. Biochem. 184:1990;244-248
67. Barany G., Merrifield R.B. Solid-phase peptide synthesis. Gross E., Meienhofer J. The Peptides. 1980;1-284 Academic Press, New Jork, USA
68. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 177-180
69. Steward J.M., Young J.D. Solide Phase Peptide Synthesis. 1984;Pierce Chemical Company, Rockford, IL, USA. pp. 31
70. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 139-140
71. Merwin J.R., Carmichael E.P., Noell G.S., DeRome M.E., Thomas W.L., Robert N., Spitalny G., Chiou H.C. CD5-mediated specific delivery of DNA to T lymphocytes: compartmentalization augmented by adenovirus. J. Immunol. Meth. 186:1995;257-266
72. Stella B., Arpicco S., Peracchia M.T., Desmaele D., Hoebeke J., Renoir M., D'Angelo J., Cattel L., Couvreur P. Design of folic acid-conjugated nanoparticles for drug targeting. J. Pharm. Sci. 89:2000;1452-1464
73. Lee E.S., Na K., Bae Y.H. Polymeric micelle for tumor pH and folate-mediated targeting. J. Controlled Release. 91:2003;103-113
74. Bobbitt J.M. Periodate oxidation of carbohydrates. Adv. Carbohydr. Chem. 11:1956;1-41
75. Hermanson T.H. Bioconjugate Techniques. 2004;Academic Press, San Diego, CA, USA. pp. 114-116
76. Hermanson T.H. Bioconjugate Techniques. 2004;Academic Press, San Diego, CA, USA. pp. 185
77. Peng L., Calton G.J., Burnett J.W. Effect of borohydride reduction on antibodies. Appl. Biochem. Biotechnol. 14:1987;91-99
78. Zanta M.A., Boussif O., Adib A., Behr J.P. In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug. Chem. 8:1997;839-844
79. Wagner E., Cotten M., Mechtler K., Kirlappos H., Birnstiel M.L. DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. Bioconjug. Chem. 2:1991;226-231
80. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 138
81. Erbacher P., Roche A.C., Monsigny M., Midoux P. Glycosylated polylysine/DNA complexes: gene transfer efficiency in relation with the size and the sugar substitution level of glycosylated polylysines and with the plasmid size. Bioconjug. Chem. 6:1995;401-410
82. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 148
83. Partis M.D., Griffiths D.G., Roberts G.C., Beechey R.B. Crosslinking of protein by w-maleimido alkanoyl N-hydroxysuccinimido esters. J. Protein Chem. 2:1983;263-277
84. Heitz J.R., Anderson C.D., Anderson B.M. Inactivation of yeast alcohol dehydrogenase by N-alkylmaleimides. Arch. Biochem. Biophys. 127:1968;627-636
85. Brewer C.F., Riehm J.P. Evidence for possible nonspecific reactions between N-ethylmaleimide androteins. Anal. Biochem. 18:1967;248-255
86. Olivier J.C., Huertas R., Lee H.J., Calon F., Pardridge W.M. Synthesis of pegylated immunonanoparticles. Pharm. Res. 19:2002;1137-1143
87. Leamon C.P., Weigl D., Hendren R.W. Folate copolymer-mediated transfection of cultured cells. Bioconjug. Chem. 10:1999;947-957
88. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 228-232
89. Hermanson T.H. Bioconjugate Techniques. 2004;Academic Press, San Diego, CA, USA. pp. 64-66
90. Carlsson J., Drevin H., Axen R. Protein thiolation and reversible protein-protein conjugation. N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem. J. 173:1978;723-737
91. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 77-83
92. Erbacher P., Remy J.S., Behr J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6:1999;138-145
93. Wagner E., Zenke M., Cotten M., Beug H., Birnstiel M.L. Transferrin-polycation conjugates as carriers for DNA uptake into cells. Proc. Natl Acad. Sci. USA. 87:1990;3410-3414
94. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 570-571
95. Green N.M., Konieczny L., Toms E.J., Valentine R.C. Use of bifunctional biotinyl compounds to determine the arrangement of subunits in avidin. Biochem. J. 125:1971;781-791
96. Hermanson T.H. Bioconjugate Techniques. 1996;Academic Press, San Diego, CA, USA. pp. 375-384
97. Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D.T., Birnstiel M.L. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl Acad. Sci. USA. 89:1992;6099-6103
98. Xu B., Wiehle S., Roth J.A., Cristiano R.J. The contribution of poly-L-lysine, epidermal growth factor and streptavidin to EGF/PLL/DNA polyplex formation. Gene Ther. 5:1998;1235-1243
99. Langer R., Peppas N.A. Advances in biomaterials, drug delivery, and bionanotechnology. AIChE J. 49:2003;2990-3006
100. Lee K.Y., Mooney D.J. Hydrogels for tissue engineering. Chem. Rev. 101:2001;1869-1879
101. Drury J.L., Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 24:2003;4337-4351
102. Eiselt P., Lee Kuen Y., Mooney David J. Rigidity of two-component hydrogels prepared from alginate and poly(ethylene glycol)-diamines. Macromolecules. 32:1999;5561-5566
103. Lee Kuen Y., Rowley Jon A., Eiselt P., Moy Erick M., Bouhadir Kamal H., Mooney David J. Controlling mechanical and swelling properties of alginate hydrogels independently by cross-linker type and cross-linking density. Macromolecules. 33:2000;4291-4294
104. Rowley J.A., Madlambayan G., Mooney D.J. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 20:1999;45-53
105. Loebsack A., Greene K., Wyatt S., Culberson C., Austin C., Beiler R., Roland W., Eiselt P., Rowley J., Burg K., Mooney D., Holder W., Halberstadt C. In vivo characterization of a porous hydrogel material for use as a tissue bulking agent. J. Biomed. Mater. Res. 57:2001;575-581
106. Rowley J.A., Mooney D.J. Alginate type and RGD density control myoblast phenotype. J. Biomed. Mater. Res. 60:2002;217-223
107. Suzuki Y., Tanihara M., Suzuki K., Saitou A., Sufan W., Nishimura Y. Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. J. Biomed. Mater. Res. 50:2000;405-409
108. Francis Suh J.-K., Matthew H.W.T. Application of chitosan-based polysaccharide biomaterials in cartilage tissue engineering: a review. Biomaterials. 21:2000;2589-2598
109. Wang Y.C., Kao S.H., Hsieh H.J. A chemical surface modification of chitosan by glycoconjugates to enhance the cell-biomaterial interaction. Biomacromolecules. 4:2003;224-231
110. Zisch A.H., Schenk U., Schense J.C., Sakiyama-Elbert S.E., Hubbell J.A. Covalently conjugated VEGF-fibrin matrices for endothelialization. J. Controlled Release. 72:2001;101-113
111. Schense J.C., Hubbell J.A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bionconjug. Chem. 10:1999;75-81
112. Cruise G.M., Scharp D.S., Hubbell J.A. Characterization of permeability and network structure of interfacially photopolymerized poly(ethylene glycol) diacrylate hydrogels. Biomaterials. 19:1998;1287-1294
113. Drumheller P.D., Hubbell J.A. Polymer networks with grafted cell adhesion peptides for highly biospecific cell adhesive substrates. Anal. Biochem. 222:1994;380-388
114. Burdick J.A., Anseth K.S. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 23:2002;4315-4323
115. Hern D.L., Hubbell J.A. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J. Biomed. Mater. Res. 39:1998;266-276
116. Jo S., Engel P.S., Mikos A.G. Synthesis of poly(ethylene glycol)-tethered poly(propylene fumarate) and its modification with GRGD peptide. Polymer. 41:2000;7595-7604
117. Jo S., Shin H., Mikos A.G. Modification of oligo(poly(ethylene glycol) fumarate) macromer with a GRGD peptide for the preparation of functionalized polymer networks. Biomacromolecules. 2:2001;255-261
118. Shin H., Jo S., Mikos A.G. Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethyleneglycol) spacer. J. Biomed. Mater. Res. 61:2002;169-179
119. Stile R.A., Healy K.E. Thermo-responsive peptide-modified hydrogels for tissue regeneration. Biomacromolecules. 2:2001;185-194
120. Plant G.W., Woerly S., Harvey A.R. Hydrogels containing peptide or aminosugar sequences implanted into the rat brain: influence on cellular migration and axonal growth. Exp. Neurol. 143:1997;287-299
121. Tong Y.W., Shoichet M.S. Peptide surface modification of poly(tetrafluoroethylene-co-hexafluoropropylene) enhances its interaction with central nervous system neurons. J. Biomed. Mater. Res. 42:1998;85-95
122. Tong Y.W., Shoichet M.S. Enhancing the neuronal interaction on fluoropolymer surfaces with mixed peptides or spacer group linkers. Biomaterials. 22:2001;1029-1034
123. Lin H.B., Garcia-Echeverria C., Asakura S., Sun W., Mosher D.F., Cooper S.L. Endothelial cell adhesion on polyurethanes containing covalently attached RGD-peptides. Biomaterials. 13:1992;905-914
124. Lin Y.S., Wang S.S., Chung T.W., Wang Y.H., Chiou S.H., Hsu J.J., Chou N.K., Hsieh K.H., Chu S.H. Growth of endothelial cells on different concentrations of Gly-Arg-Gly-Asp photochemically grafted in polyethylene glycol modified polyurethane. Artif. Organs. 25:2001;617-621
125. Park K.H. Arg-Gly-Asp (RGD) sequence conjugated in a synthetic copolymer bearing a sugar moiety for improved culture of parenchymal cells (hepatocytes). Biotechnol. Lett. 24:2002;1401-1406
126. Ito Y. Tissue engineering by immobilized growth factors. Mater. Sci. Eng. C6:1998;267-274
127. Ito Y., Zheng J., Imanishi Y., Yonezawa K., Kasuga M. Protein-free cell culture on an artificial substrate with covalently immobilized insulin. Proc. Natl Acad. Sci. USA. 93:1996;3598-3601
128. Schaffner P., Meyer J., Dard M., Wenz R., Nies B., Verrier S., Kessler H., Kantlehner M. Induced tissue integration of bone implants by coating with bone selective RGD-peptides in vitro and in vivo studies. J. Mater. Sci.: Mater. Med. 10:1999;837-839
129. Yoon J.J., Nam Y.S., Kim J.H., Park T.G. Surface immobilization of galactose onto aliphatic biodegradable polymers for hepatocyte culture. Biotechnol. Bioeng. 78:2002;1-10
130. Quirk R.A., Chan W.C., Davies M.C., Tendler S.J.B., Shakesheff K.M. Poly(L-lysine)-GRGDS as a biomimetic surface modifier for poly(lactic acid). Biomaterials. 22:2001;865-872
131. Cook A.D., Hrkach J.S., Gao N.N., Johnson I.M., Pajvani U.B., Cannizzaro S.M., Langer R. Characterization and development of RGD-peptide-modified poly(lactic acid-co-lysine) as an interactive, resorbable biomaterial. J. Biomed. Mater. Res. 35:1997;513-523
132. Tessmar J.K., Mikos A.G., Gopferich A. Amine-reactive biodegradable diblock copolymers. Biomacromolecules. 3:2002;194-200
133. Fischbach C., Tessmar J., Lucke A., Schnell E., Schmeer G., Blunk T., Gopferich A. Does UV irradiation affect polymer properties relevant to tissue engineering? Surf. Sci. 491:2001;333-345
134. Allemann E., Gurny R., Doelker E. Drug-loaded nanoparticles. Preparation methods and drug targeting issues. Eur. J. Pharm. Biopharm. 39:1993;173-191
135. Ogris M., Brunner S., Schuller S., Kircheis R., Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:1999;595-605
136. O'Mullane J.E., Petrak K., Hutchinson L.E.F., Tomlinson E. The effect of adsorbed coats of poloxamers 237 and 338 on the in vitro aggregation and in vivo distribution of polystyrene latex (PSL) particles. Int. J. Pharm. 63:1990;177-180
137. Bazile D.V., Ropert C., Huve P., Verrecchia T., Marland M., Frydman A., Veillard M., Spenleuhauer G. Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats. Biomaterials. 13:1992;1093-1102
138. Mitra S., Gaur U., Ghosh P.C., Maitra A.N. Tumour targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier. J. Controlled Release. 74:2001;317-323
139. Storm G., Belliot S.O., Daemen T., Lasic D.D. Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv. Drug Deliv. Rev. 17:1995;31-48
140. Kircheis R., Wightman L., Schreiber A., Robitza B., Rossler V., Kursa M., Wagner E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8:2001;28-40
141. Bazile D., Prud'homme C., Bassoullet M.T., Marland M., Spenlehauer G., Veillard M. Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system. J. Pharm. Sci. 84:1995;493-498
142. Stolnik S., Illum L., Davis S.S. Long circulating microparticulate drug carriers. Adv. Drug Deliv. Rev. 16:1995;195-214
143. Na K., Bum Lee T., Park K.H., Shin E.K., Lee Y.B., Choi H.K. Self-assembled nanoparticles of hydrophobically-modified polysaccharide bearing vitamin H as a targeted anti-cancer drug delivery system. Eur. J. Pharm. Sci. 18:2003;165-173
144. Wagner E., Curiel D., Cotten M. Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis. Adv. Drug Deliv. Rev. 14:1994;113-135
145. Putnam E.A., Yen N., Gallick G.E., Steck P.A., Fang K., Akpakip B., Gazdar A.F., Roth J.A. Autocrine growth stimulation by transforming growth factor-alpha in human non-small cell lung cancer. Surg. Oncol. 1:1992;49-60
146. Li Y., Ogris M., Wagner E., Pelisek J., Ruffer M. Nanoparticles bearing polyethyleneglycol-coupled transferrin as gene carriers: preparation and in vitro evaluation. Int. J. Pharm. 259:2003;93-101
147. Pan D., Turner J.L., Wooley K.L. Folic acid-conjugated nanostructured materials designed for cancer cell targeting. Chem. Commun. 19:2003;2400-2401
148. Patchornik A., Berger A., Katchalski E. Poly-L-histidine. J. Am. Chem. Soc. 79:1957;5227-5230
149. Wang C.Y., Huang L. Polyhistidine mediates an acid-dependent fusion of negatively charged liposomes. Biochemistry. 23:1984;4409-4416
150. Wagner E., Cotten M., Foisner R., Birnstiel M.L. Transferrin-polycation- DNA complexes: the effect of polycations on the structure of the complex and DNA delivery to cells. Proc. Natl Acad. Sci. USA. 88:1991;4255-4259
151. Godbey W.T., Wu K.K., Mikos A.G. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res. 45:1999;268-275
152. Bieber T., Meissner W., Kostin S., Niemann A., Elsasser H.P. Intracellular route and transcriptional competence of polyethylenimine-DNA complexes. J. Controlled Release. 82:2002;441-454
153. von Harpe A., Petersen H., Li Y., Kissel T. Characterization of commercially available and synthesized polyethylenimines for gene delivery. J. Controlled Release. 69:2000;309-322
154. Erbacher P., Bettinger T., Belguise-Valladier P., Zou S., Coll J.L., Behr J.P., Remy J.S. Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J. Gene Med. 1:1999;210-222
155. van Steenis J.H., van Maarseveen E.M., Verbaan F.J., Verrijk R., Crommelin D.J.A., Storm G., Hennink W.E. Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J. Controlled Release. 87:2003;167-176
156. Kabanov A.V., Kabanov V.A. DNA complexes with polycations for the delivery of genetic material into cells. Bioconjug. Chem. 6:1995;7-20
157. Mislick K.A., Baldeschwieler J.D., Kayyem J.F., Meade T.J. Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery. Bioconjug. Chem. 6:1995;512-515
158. Curiel D.T., Agarwal S., Wagner E., Cotten M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl Acad. Sci. USA. 88:1991;8850-8854
159. Blumenthal R., Seth P., Willingham M.C., Pastan I. pH-dependent lysis of liposomes by adenovirus. Biochemistry. 25:1986;2231-2237
160. Cotten M., Langle-Rouault F., Kirlappos H., Wagner E., Mechtler K., Zenke M., Beug H., Birnstiel M.L. Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. Proc. Natl Acad. Sci. USA. 87:1990;4033-4037
161. Plank C., Oberhauser B., Mechtler K., Koch C., Wagner E. The influence of endosome-disruptive peptides on gene transfer using synthetic virus-like gene transfer systems. J. Biol. Chem. 269:1994;12918-12924
162. Smith L.C., Duguid J., Wadhwa M.S., Logan M.J., Tung C.H., Edwards V., Sparrow J.T. Synthetic peptide-based DNA complexes for nonviral gene delivery. Adv. Drug Deliv. Rev. 30:1998;115-131
163. Chen J., Gamou S., Takayanagi A., Shimizu N. A novel gene delivery system using EGF receptor-mediated endocytosis. FEBS Lett. 338:1994;167-169
164. Plank C., Zatloukal K., Cotten M., Mechtler K., Wagner E. Gene transfer into hepatocytes using asialoglycoprotein receptor mediated endocytosis of DNA complexed with an artificial tetra-antennary galactose ligand. Bioconjug. Chem. 3:1992;533-539
165. Godbey W.T., Wu K.K., Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl Acad. Sci. USA. 96:1999;5177-5181
166. Bettinger T., Remy J.S., Erbacher P. Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes. Bioconjug. Chem. 10:1999;558-561
167. Kircheis R., Blessing T., Brunner S., Wightman L., Wagner E. Tumor targeting with surface-shielded ligand-polycation DNA complexes. J. Controlled Release. 72:2001;165-170
168. Lee H., Kim T.H., Park T.G. A receptor-mediated gene delivery system using streptavidin and biotin-derivatized, pegylated epidermal growth factor. J. Controlled Release. 83:2002;109-119
169. Kataoka K., Harada A., Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv. Rev. 47:2001;113-131
170. Harma H., Soukka T., Lonnberg S., Paukkunen J., Tarkkinen P., Lovgren T. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence. Luminescence. 15:2000;351-355
171. Wang D., Robinson D.R., Kwon G.S., Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D,L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J. Controlled Release. 57:1999;9-18
172. Nishikawa M., Huang L. Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum. Gene Ther. 12:2001;861-870
173. Donahue R.E., Kessler S.W., Bodine D., McDonagh K., Dunbar C., Goodman S., Agricola B., Byrne E., Raffeld M., Moen R. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1992;1125-1135
174. Parthasarathi S., Varela-Echavarria A., Ron Y., Preston B.D., Dougherty J.P. Genetic rearrangements occurring during a single cycle of murine leukemia virus vector replication: characterization and implications. J. Virol. 69:1995;7991-8000
175. Purcell D.F., Broscius C.M., Vanin E.F., Buckler C.E., Nienhuis A.W., Martin M.A. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J. Virol. 70:1996;887-897
176. Cristiano R.J., Smith L.C., Kay M.A., Brinkley B.R., Woo S.L.C. Hepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex. Proc. Natl Acad. Sci. USA. 90:1993;11548-11552